Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
- PMID: 21070637
- PMCID: PMC2993680
- DOI: 10.1186/1471-2407-10-623
Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
Abstract
Background: Oral mucosal melanoma (OMM) is a clinically rare disease with poor prognosis. Various treatment methods have been investigated with the aim of improving the prognosis. This study aimed to analyze the data of a single institution in the management of OMM.
Methods: A total of 78 consecutive OMM patients were included in this retrospective study. The intraoral lesion was treated either by cryotherapy, surgery or both; the neck was treated by neck dissection or observation; post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin was performed in some patients. The Kaplan-Meier method was used for statistical analysis.
Results: Among the 78 patients, there were 50 males and 28 females with an average age of 53.8 years (ranging from 27 to 85 years). The most common sites of OMM were the hard palate and gingiva. The main cause of death in OMM was distant metastasis. No significant difference was found between the intraoral/cervical lesion recurrence/post-operative distant metastasis and the intraoral lesion site/biopsy method/treatment method. The metastasis rate of cervical lymph node was high in the OMM patients, even in the patients with clinically negative necks. Cervical lesion recurrence was correlated with N stage and intraoral lesion recurrence. The survival period was longer in the patients with T3 staging, clinical stage III disease, with post-operative chemotherapy and without post-operative distant metastasis when compared to those patients with T4a staging, clinical stage IV disease, without post-operative chemotherapy and with post-operative distant metastasis.
Conclusions: Radical surgery including wide intraoral resection and neck dissection is recommended for OMM patients. Post-operative chemotherapy may also be beneficial for both primary and recurrent OMM patients.
Figures



Similar articles
-
Primary malignant melanoma of the oral mucosa.J Oral Maxillofac Surg. 2003 Oct;61(10):1132-9. doi: 10.1016/s0278-2391(03)00670-0. J Oral Maxillofac Surg. 2003. PMID: 14586846
-
Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jul;106(1):51-7. doi: 10.1016/j.tripleo.2008.03.003. Epub 2008 May 27. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008. PMID: 18504155
-
Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.J Oral Maxillofac Surg. 2009 Jul;67(7):1409-15. doi: 10.1016/j.joms.2008.12.021. J Oral Maxillofac Surg. 2009. PMID: 19531410
-
Oral Mucosal Melanoma.J Craniofac Surg. 2022 May 1;33(3):830-834. doi: 10.1097/SCS.0000000000008054. Epub 2021 Jul 30. J Craniofac Surg. 2022. PMID: 34334749
-
Elective neck dissection in oral carcinoma: a critical review of the evidence.Acta Otorhinolaryngol Ital. 2007 Jun;27(3):113-7. Acta Otorhinolaryngol Ital. 2007. PMID: 17883186 Free PMC article. Review.
Cited by
-
Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013.Radiat Oncol. 2016 Oct 14;11(1):137. doi: 10.1186/s13014-016-0712-9. Radiat Oncol. 2016. PMID: 27737700 Free PMC article.
-
Analysis of post-operative efficacy and pharyngeal fistula healing in patients with laryngeal cancer treated with post-operative enteral nutrition support nursing combined with early oral feeding.Oncol Lett. 2020 Jun;19(6):3964-3970. doi: 10.3892/ol.2020.11503. Epub 2020 Apr 1. Oncol Lett. 2020. PMID: 32382341 Free PMC article.
-
Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma.Oncotarget. 2017 Apr 25;8(17):29080-29090. doi: 10.18632/oncotarget.16175. Oncotarget. 2017. PMID: 28404968 Free PMC article.
-
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study.Tumour Biol. 2013 Jun;34(3):1595-603. doi: 10.1007/s13277-013-0690-6. Epub 2013 Feb 15. Tumour Biol. 2013. PMID: 23412976
-
Oral malignant melanoma: A report of two cases with BRAF molecular analysis.Oncol Lett. 2014 Sep;8(3):1283-1286. doi: 10.3892/ol.2014.2314. Epub 2014 Jul 4. Oncol Lett. 2014. PMID: 25120707 Free PMC article.
References
-
- Barker BF, Carpenter WM, Daniels TE, Kahn MA, Leider AS, Lozada-Nur F, Lynch DP, Melrose R, Merrell P, Morton T, Peters E, Regezi JA, Richards SD, Rick GM, Rohrer MD, Slater L, Stewart JC, Tomich CE, Vickers RA, Wood NK, Young SK. Oral mucosal melanomas: the WESTOP Banff workshop proceedings, Western Society of Teachers of Oral Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:672–9. doi: 10.1016/S1079-2104(97)90318-8. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical